Results

Total Results: 685 records

Showing results for "cardiovascular".
Users also searched for: statin

  1. effectivehealthcare.ahrq.gov/sites/default/files/considerations-for-statistical-chapter-10.pptx
    January 01, 2013 - Ray and colleagues (2001) reported effect modification by cardiovascular disease risk, derived and summarized
  2. effectivehealthcare.ahrq.gov/sites/default/files/pdf/atypical-antipsychotics-off-label-update_research-protocol.pdf
    May 19, 2010 - Mortality Cardiovascular Myocardial infarction Arrhythmia - tachycardia Blood pressure increase
  3. effectivehealthcare.ahrq.gov/sites/default/files/pdf/heart-failure-natriuretic-peptide_research-protocol.pdf
    December 20, 2011 - There is also suggestion that they add useful information to the standard cardiovascular disease (CVD … B-type natriuretic peptides and cardiovascular risk: systematic review and meta-analysis of 40 prospective
  4. effectivehealthcare.ahrq.gov/sites/default/files/pdf/methods-future-value-of-information_research.pdf
    June 01, 2011 - Simulation/ bootstrapping, parametric and nonparametric Application Comparison of five trials in cardiovascular … on assumptions [see also Data] QALYs [see also Data] of QALYs [see also Data] risk of cardiovascular … trial35, 36 All: Trial costs: assumptions C: Probability of stopping: assumptions - Risk of cardiovascular
  5. effectivehealthcare.ahrq.gov/sites/default/files/related_files/mhs4-active-infection-rapid-response.pdf
    May 01, 2024 - admitted patients for MRSA colonization Moderate Sun, 202219 Retrospective cohort Single cardiovascular … One study19 examined patients undergoing cardiovascular surgery at two campuses of an academic medical … and targeted decolonization bundle protocols in cardiac surgery: a nine-year review of a regional cardiovascular
  6. effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-215-depression-older-adults-executive-summary.pdf
    March 01, 2019 - post-hoc analysis on a RCT, risk of falls on duloxetine may be associated with the presence of any cardiovascular
  7. effectivehealthcare.ahrq.gov/sites/default/files/pdf/pediatric-cancer-survivorship-protocol.pdf
    June 01, 2020 - These late effects could range in severity and complexity, and commonly include cardiovascular disease
  8. effectivehealthcare.ahrq.gov/sites/default/files/pdf/lysosomal-storage-diseases-therapies_research-protocol.pdf
    November 15, 2012 - expectancy is 40 - 50 yrs, with cause of death usually due to a decline in kidney function or to cardiovascular
  9. S103 (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/s103.pdf
    October 01, 2007 - Inverse Probability-Weighted Estimators © 2007 Lippincott Williams & Wilkins S105 hypertension, cardiovascular
  10. effectivehealthcare.ahrq.gov/sites/default/files/related_files/management-adhd-adults-protocol-amendment.pdf
    January 08, 2025 - : • Adherence • Satisfaction with treatment Adverse effects of intervention Patient level: cardiovascular … Short-term effects of lisdexamfetamine dimesylate on cardiovascular parameters in a 4-week clinical
  11. effectivehealthcare.ahrq.gov/sites/default/files/related_files/management-adhd-adults-protocol.pdf
    June 10, 2024 - : • Adherence • Satisfaction with treatment Adverse effects of intervention Patient level: cardiovascular … Short-term effects of lisdexamfetamine dimesylate on cardiovascular parameters in a 4-week clinical
  12. effectivehealthcare.ahrq.gov/sites/default/files/related_files/misuse-adhd-prescription-rapid-research.pdf
    July 01, 2025 - Key Question 2: What Are the Shorter Term (e.g., Overdose) And Longer Term (e.g., Cardiovascular) Health … studies on the long-term health effects of prescription stimulant misuse, including neurological or cardiovascular … KQ2: What are the shorter term (e.g., overdose) and longer term (e.g., cardiovascular) health consequences … stimulant(s), if named • Outcome o Short-term  Overdoses, fatal and non-fatal  Health measures (cardiovascular … Dextroamphetamine Medications: 26%, Narcotic Pain Relievers: 16%, Antidepressants: 10%, Antipsychotics: 7%, Cardiovascular
  13. effectivehealthcare.ahrq.gov/sites/default/files/pdf/cancer-anemia-update_research-protocol.pdf
    June 16, 2010 - Chronic anemia may result in severe organ damage affecting the cardiovascular system, immune system, … WARNINGS: INCREASED MORTALITY, SERIOUS CARDIOVASCULAR EVENTS, THROMBOEMBOLIC EVENTS, STROKE and INCREASED
  14. effectivehealthcare.ahrq.gov/sites/default/files/pdf/health-systems-research.pdf
    October 01, 2017 - (National Cardiovascular Service Line, Catholic Health Initiatives); (8) Paula Santrach, M.D. … community clinics, and living communities Chief Quality Officer Vice President of Analytics Head, Cardiovascular
  15. effectivehealthcare.ahrq.gov/sites/default/files/related_files/medical-test-reviews-options-summarizing.ppt
    June 01, 2012 - It is associated with daytime somnolence, cardiovascular morbidity, diabetes, and other adverse outcomes … It is present in 2 to 4 percent of middle-aged adults and can lead to daytime somnolence, cardiovascular
  16. effectivehealthcare.ahrq.gov/sites/default/files/pdf/calcineurin-inhibitor_research-protocol.pdf
    October 08, 2014 - which are significant concerns because the main cause of death among kidney transplant recipients is cardiovascular … A comparison of the effects of C2-cyclosporine and C0-tacrolimus on renal function and cardiovascular
  17. effectivehealthcare.ahrq.gov/sites/default/files/pdf/tonsillectomy_research-protocol.pdf
    February 10, 2016 - neurocognitive  functioning,  enuresis,  parasomnias,  and  restless  sleep,  and  it   may  also  reverse  cardiovascular … Systematic  review  of  effects  of  adenotonsillectomy  on   cardiovascular  parameters  in  children
  18. effectivehealthcare.ahrq.gov/sites/default/files/ch_8-user-guide-to-ocer_130129.pdf
    October 01, 2013 - To illustrate, the Cardiovascular Health Study is a large cohort study that was designed to identify … The Cardiovascular Health Study: design and rationale.
  19. effectivehealthcare.ahrq.gov/sites/default/files/medical-test-reviews-options-summarizing.ppt
    June 01, 2012 - It is associated with daytime somnolence, cardiovascular morbidity, diabetes, and other adverse outcomes … It is present in 2 to 4 percent of middle-aged adults and can lead to daytime somnolence, cardiovascular
  20. effectivehealthcare.ahrq.gov/sites/default/files/related_files/migraine-emergency_executive.pdf
    November 01, 2012 - Migraine and cardiovascular disease: a population-based study. Neurology. 2010;74(8):628-35. … Migraine and cardiovascular disease: systematic review and meta-analysis. BMJ. 2009;339:b3914.

Search the AHRQ Archive

Information and reports more than 5 years old may be found in the AHRQ Archive site.

Search Archive

Search Within A Specific AHRQ Site

You selected to view results for the following site: